Interestingly, the percentage of circulating MDSCs (defined by cell surface phenotype, i.e., CD33+CD11b+HLA-DRlow/−) in septic patients was consistent with the range demonstrated to be present in the circulation of cancer patients [45, 46]. The gene discussed is CD33; the disease is cancer.